| Originalspråk | engelska |
|---|---|
| Tidskrift | Clinical Chemistry (Washington, DC) |
| Volym | 62 |
| Utgåva | 10 |
| Sidor (från-till) | 1390-1400 |
| Antal sidor | 11 |
| ISSN | 0009-9147 |
| DOI | |
| Status | Publicerad - okt 2016 |
| MoE-publikationstyp | A1 Tidskriftsartikel-refererad |
Vetenskapsgrenar
- 217 Medicinsk teknik
- 3111 Biomedicinska vetenskaper
Citera det här
}
A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources. / Gidwani, Kamlesh; Huhtinen, Kaisa; Kekki, Henna; van Vliet, Sandra; Hynninen, Johanna; Koivuviita, Niina; Perheentupa, Anti; Poutanen, Matti; Auranen, Annika; Grenman, Seija; Lamminmaki, Urpo; Carpen, Olli; van Kooyk, Yvette; Pettersson, Kim.
I: Clinical Chemistry (Washington, DC), Vol. 62, Nr. 10, 10.2016, s. 1390-1400.Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review
TY - JOUR
T1 - A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources
AU - Gidwani, Kamlesh
AU - Huhtinen, Kaisa
AU - Kekki, Henna
AU - van Vliet, Sandra
AU - Hynninen, Johanna
AU - Koivuviita, Niina
AU - Perheentupa, Anti
AU - Poutanen, Matti
AU - Auranen, Annika
AU - Grenman, Seija
AU - Lamminmaki, Urpo
AU - Carpen, Olli
AU - van Kooyk, Yvette
AU - Pettersson, Kim
PY - 2016/10
Y1 - 2016/10
KW - COLON-CANCER PATIENTS
KW - OVARIAN-CANCER
KW - GLYCOSYLATION
KW - IDENTIFICATION
KW - RECOGNITION
KW - ANTIGENS
KW - RECEPTOR
KW - GLYCANS
KW - GLYCOME
KW - BINDING
KW - 217 Medical engineering
KW - 3111 Biomedicine
U2 - 10.1373/clinchem.2016.257691
DO - 10.1373/clinchem.2016.257691
M3 - Article
VL - 62
SP - 1390
EP - 1400
JO - Clinical Chemistry (Washington, DC)
JF - Clinical Chemistry (Washington, DC)
SN - 0009-9147
IS - 10
ER -